| 000 | 01646 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512045456.0 | ||
| 264 | 0 | _c19880407 | |
| 008 | 198804s 0 0 eng d | ||
| 022 | _a0300-0605 | ||
| 024 | 7 |
_a10.1177/030006058701500609 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbdel Aal, H | |
| 245 | 0 | 0 |
_aClinical experience with 0.05% halometasone/1% triclosan cream in the treatment of acute infected and infection-prone eczema in Egypt. _h[electronic resource] |
| 260 |
_bThe Journal of international medical research _c |
||
| 300 |
_a383-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBetamethasone _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aEczema _xdrug therapy |
| 650 | 0 | 4 | _aEgypt |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOintments |
| 650 | 0 | 4 |
_aPhenyl Ethers _xadministration & dosage |
| 650 | 0 | 4 |
_aSkin Diseases, Infectious _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTriclosan _xadministration & dosage |
| 700 | 1 | _aAbdallah, M A | |
| 700 | 1 | _aIskandar, I O | |
| 700 | 1 | _aSalama, N R | |
| 773 | 0 |
_tThe Journal of international medical research _gvol. 15 _gno. 6 _gp. 383-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/030006058701500609 _zAvailable from publisher's website |
| 999 |
_c3331086 _d3331086 |
||